Case study on how XtalPi is helping pfizer scientists predict and optimize the crystalline forms of drug candidates.
to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery
To date, XtalPi has raised over 20 million USD, making it one of the top-funded AI-powered biotechs.
This collaboration serves to explore and showcase how XtalPi’s algorithm-based solution could accelerate the drug solid-form screening and designing process.
Thanks to AWS and Spot Instances, we were able to build a flexible and scalable high-performance-computing cluster in the cloud, and reach an ideal cost efficiency.